Research Initiative Supporting Excellence at the University of Cincinnati (RISE-UC): A Program to Develop and Support Research-Active Faculty Members.

"Other disclosures: M.S. was affiliated with the University of Cincinnati during the implementation of RISE-UC but is now a faculty member of the Department of Medicine, University of New Mexico School of Medicine, and a senior clinician–scientist investigator with the Department of Veterans Affairs. K.J.H. provides consulting for Boston Scientific, Inc. S.S. provides consulting and collaborative research studies to the Foundation Leducq (CURE PLaN), Red Saree, Inc., Greater Cincinnati Tamil Sangam, Novo Nordisk, Pfizer, AavantiBio, Inc., AstraZeneca, MyoKardia, Inc., Merck, and Amgen, but this work is unrelated to the content of this article. C.J.F. serves as an advisor for ViiV Healthcare and Theratechnologies, Inc. He also receives research grants to the institution from Gilead Sciences, Inc., ViiV Healthcare, Merck, Moderna, and CytoDyn, all outside of the content of this article."

"Funding/Support: This work was funded by the Department of Internal Medicine at the University of Cincinnati."